193 related articles for article (PubMed ID: 20142713)
1. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Goto H; Iwasaki T
Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
[TBL] [Abstract][Full Text] [Related]
2. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Iwasaki T; Ohno A; Goto H
Retina; 2011 Oct; 31(9):1951-7. PubMed ID: 21610567
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Takeuchi M; Kezuka T; Iwasaki T; Goto H
Diabet Med; 2008 Jul; 25(7):875-7. PubMed ID: 18644076
[TBL] [Abstract][Full Text] [Related]
4. Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
Umazume K; Usui Y; Wakabayashi Y; Okunuki Y; Kezuka T; Goto H
Retina; 2013 May; 33(5):1020-5. PubMed ID: 23095769
[TBL] [Abstract][Full Text] [Related]
5. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
6. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
7. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy.
Reverter JL; Nadal J; Fernández-Novell JM; Ballester J; Ramió-Lluch L; Rivera MM; Elizalde J; Abengoechea S; Guinovart JJ; Rodríguez-Gil JE
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1378-82. PubMed ID: 18978347
[TBL] [Abstract][Full Text] [Related]
11. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
12. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
Schoenberger SD; Kim SJ; Sheng J; Rezaei KA; Lalezary M; Cherney E
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5906-11. PubMed ID: 22871833
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Nov; 116(11):2165-9. PubMed ID: 19700197
[TBL] [Abstract][Full Text] [Related]
14. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy.
Nawaz MI; Van Raemdonck K; Mohammad G; Kangave D; Van Damme J; Abu El-Asrar AM; Struyf S
Exp Eye Res; 2013 Apr; 109():67-76. PubMed ID: 23352833
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
16. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
17. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
Shimada H; Akaza E; Yuzawa M; Kawashima M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
[TBL] [Abstract][Full Text] [Related]
18. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
[TBL] [Abstract][Full Text] [Related]
19. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
20. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]